http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103265537-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b7dec7a3442e878cdbf561c8433b8a6 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 |
filingDate | 2013-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c27152073aec21288487276818b60e2f |
publicationDate | 2013-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103265537-A |
titleOfInvention | Antitumor compound, its preparation method and use |
abstract | The present invention relates to the field of medicines related to anticancer. Specifically, the present invention relates to an antitumor active compound having the structure of formula I and its preparation method, pharmaceutical composition and use. . |
priorityDate | 2013-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.